In vitro efficacy of antimalarial drugs against circulating strains of the SARS-CoV-2 virus that causes COVID-19 in Panama.
- Funded by Secretaría Nacional de Ciencia, Tecnología e Innovación (SENACYT)
- Total publications:0 publications
Grant number: COVID19-041
Grant search
Key facts
Disease
COVID-19Start & end year
N/AKnown Financial Commitments (USD)
$200,000Funder
Secretaría Nacional de Ciencia, Tecnología e Innovación (SENACYT)Principal Investigator
Dr. Nicanor Tercero Obaldía RodríguezResearch Location
PanamaLead Research Institution
Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES)Research Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
Prophylactic use of treatmentsSpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable